Global Ethinyl Estradiol and Norgestimate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Ethinyl Estradiol and Norgestimate Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
This product is an over-the-counter oral contraceptive drug
Ethinyl Estradiol and Norgestimate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ethinyl Estradiol and Norgestimate market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Contraceptive and Moderate Acne are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Ethinyl Estradiol and Norgestimate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Ethinyl Estradiol and Norgestimate key manufacturers include Sine Pharma, Xianju Pharmaceuticals, Aurobindo Pharma, Lupin, Glenmark Pharma, Amneal Pharma, Viatris, Naari and Xiromed, etc. Sine Pharma, Xianju Pharmaceuticals, Aurobindo Pharma are top 3 players and held % sales share in total in 2022.
Ethinyl Estradiol and Norgestimate can be divided into 0.035Mg/0.25Mg, 0.035Mg/0.6Mg, 0.025Mg/0.18Mg and Other, etc. 0.035Mg/0.25Mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Ethinyl Estradiol and Norgestimate is widely used in various fields, such as Contraceptive and Moderate Acne, etc. Contraceptive provides greatest supports to the Ethinyl Estradiol and Norgestimate industry development. In 2022, global % sales of Ethinyl Estradiol and Norgestimate went into Contraceptive filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ethinyl Estradiol and Norgestimate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Sine Pharma
Xianju Pharmaceuticals
Aurobindo Pharma
Lupin
Glenmark Pharma
Amneal Pharma
Viatris
Naari
Xiromed
Novast
Teva
Apotex
Eudo
JNJ
Pfizer
Segment by Type
0.035Mg/0.25Mg
0.035Mg/0.6Mg
0.025Mg/0.18Mg
Other
Contraceptive
Moderate Acne
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Ethinyl Estradiol and Norgestimate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ethinyl Estradiol and Norgestimate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ethinyl Estradiol and Norgestimate industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Ethinyl Estradiol and Norgestimate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ethinyl Estradiol and Norgestimate introduction, etc. Ethinyl Estradiol and Norgestimate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Ethinyl Estradiol and Norgestimate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Ethinyl Estradiol and Norgestimate report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Ethinyl Estradiol and Norgestimate market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Contraceptive and Moderate Acne are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Ethinyl Estradiol and Norgestimate industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Ethinyl Estradiol and Norgestimate key manufacturers include Sine Pharma, Xianju Pharmaceuticals, Aurobindo Pharma, Lupin, Glenmark Pharma, Amneal Pharma, Viatris, Naari and Xiromed, etc. Sine Pharma, Xianju Pharmaceuticals, Aurobindo Pharma are top 3 players and held % sales share in total in 2022.
Ethinyl Estradiol and Norgestimate can be divided into 0.035Mg/0.25Mg, 0.035Mg/0.6Mg, 0.025Mg/0.18Mg and Other, etc. 0.035Mg/0.25Mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Ethinyl Estradiol and Norgestimate is widely used in various fields, such as Contraceptive and Moderate Acne, etc. Contraceptive provides greatest supports to the Ethinyl Estradiol and Norgestimate industry development. In 2022, global % sales of Ethinyl Estradiol and Norgestimate went into Contraceptive filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ethinyl Estradiol and Norgestimate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Sine Pharma
Xianju Pharmaceuticals
Aurobindo Pharma
Lupin
Glenmark Pharma
Amneal Pharma
Viatris
Naari
Xiromed
Novast
Teva
Apotex
Eudo
JNJ
Pfizer
Segment by Type
0.035Mg/0.25Mg
0.035Mg/0.6Mg
0.025Mg/0.18Mg
Other
Segment by Application
Contraceptive
Moderate Acne
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Ethinyl Estradiol and Norgestimate market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Ethinyl Estradiol and Norgestimate, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Ethinyl Estradiol and Norgestimate industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Ethinyl Estradiol and Norgestimate in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Ethinyl Estradiol and Norgestimate introduction, etc. Ethinyl Estradiol and Norgestimate Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Ethinyl Estradiol and Norgestimate market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
